| Richard Stewart, NP | |
|
206 Alaska Frontage Rd, Belgrade, MT 59714-7909 | |
| (406) 414-3334 | |
| (406) 414-1271 |
| Full Name | Richard Stewart |
|---|---|
| Gender | Male |
| Speciality | Nurse Practitioner |
| Experience | 27 Years |
| Location | 206 Alaska Frontage Rd, Belgrade, Montana |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1174549877 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363L00000X | Nurse Practitioner | 26193 (Montana) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Bozeman Health Deaconess Hospital | Bozeman, MT | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Bozeman Health Convenience Care Llc | 6608137096 | 17 |
| Bozeman Health Urgent Care | 3476879305 | 23 |
News Archive
Lexicon Pharmaceuticals, Inc. today announced that it is offering to sell, subject to market and other conditions, $95,000,000 of its common stock pursuant to an effective shelf registration statement in an underwritten public offering. Lexicon also intends to grant the underwriters a 30-day option to purchase up to an additional $14,250,000 of common stock to cover over-allotments, if any.
Part of our role in protecting patients is to regularly evaluate, monitor and update scientific evidence on the risks from medical devices—including issues related to the materials used in devices, such as metals.
Peregrine Pharmaceuticals, Inc., today announced that a research article titled "A Monoclonal Antibody that Binds Anionic Phospholipids on Tumor Blood Vessels Enhances the Antitumor Effect of Docetaxel on Human Breast Tumors in Mice" was published in the May 15 issue of Cancer Research.
Cigarette smoking, head injury, farming, pesticide exposure, and a lower level of education may be risk factors for idiopathic rapid eye movement sleep behavior disorder, researchers report.
› Verified 7 days ago
| Entity Name | Bozeman Health Urgent Care |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1740693761 PECOS PAC ID: 3476879305 Enrollment ID: O20150311001815 |
News Archive
Lexicon Pharmaceuticals, Inc. today announced that it is offering to sell, subject to market and other conditions, $95,000,000 of its common stock pursuant to an effective shelf registration statement in an underwritten public offering. Lexicon also intends to grant the underwriters a 30-day option to purchase up to an additional $14,250,000 of common stock to cover over-allotments, if any.
Part of our role in protecting patients is to regularly evaluate, monitor and update scientific evidence on the risks from medical devices—including issues related to the materials used in devices, such as metals.
Peregrine Pharmaceuticals, Inc., today announced that a research article titled "A Monoclonal Antibody that Binds Anionic Phospholipids on Tumor Blood Vessels Enhances the Antitumor Effect of Docetaxel on Human Breast Tumors in Mice" was published in the May 15 issue of Cancer Research.
Cigarette smoking, head injury, farming, pesticide exposure, and a lower level of education may be risk factors for idiopathic rapid eye movement sleep behavior disorder, researchers report.
› Verified 7 days ago
| Entity Name | Bozeman Health Big Sky Medical Center Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1740659952 PECOS PAC ID: 7315256872 Enrollment ID: O20151023000110 |
News Archive
Lexicon Pharmaceuticals, Inc. today announced that it is offering to sell, subject to market and other conditions, $95,000,000 of its common stock pursuant to an effective shelf registration statement in an underwritten public offering. Lexicon also intends to grant the underwriters a 30-day option to purchase up to an additional $14,250,000 of common stock to cover over-allotments, if any.
Part of our role in protecting patients is to regularly evaluate, monitor and update scientific evidence on the risks from medical devices—including issues related to the materials used in devices, such as metals.
Peregrine Pharmaceuticals, Inc., today announced that a research article titled "A Monoclonal Antibody that Binds Anionic Phospholipids on Tumor Blood Vessels Enhances the Antitumor Effect of Docetaxel on Human Breast Tumors in Mice" was published in the May 15 issue of Cancer Research.
Cigarette smoking, head injury, farming, pesticide exposure, and a lower level of education may be risk factors for idiopathic rapid eye movement sleep behavior disorder, researchers report.
› Verified 7 days ago
| Entity Name | Bozeman Health Deaconess Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1619347390 PECOS PAC ID: 4688984164 Enrollment ID: O20151112002559 |
News Archive
Lexicon Pharmaceuticals, Inc. today announced that it is offering to sell, subject to market and other conditions, $95,000,000 of its common stock pursuant to an effective shelf registration statement in an underwritten public offering. Lexicon also intends to grant the underwriters a 30-day option to purchase up to an additional $14,250,000 of common stock to cover over-allotments, if any.
Part of our role in protecting patients is to regularly evaluate, monitor and update scientific evidence on the risks from medical devices—including issues related to the materials used in devices, such as metals.
Peregrine Pharmaceuticals, Inc., today announced that a research article titled "A Monoclonal Antibody that Binds Anionic Phospholipids on Tumor Blood Vessels Enhances the Antitumor Effect of Docetaxel on Human Breast Tumors in Mice" was published in the May 15 issue of Cancer Research.
Cigarette smoking, head injury, farming, pesticide exposure, and a lower level of education may be risk factors for idiopathic rapid eye movement sleep behavior disorder, researchers report.
› Verified 7 days ago
| Entity Name | Bozeman Health Convenience Care Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1750890232 PECOS PAC ID: 6608137096 Enrollment ID: O20180227002551 |
News Archive
Lexicon Pharmaceuticals, Inc. today announced that it is offering to sell, subject to market and other conditions, $95,000,000 of its common stock pursuant to an effective shelf registration statement in an underwritten public offering. Lexicon also intends to grant the underwriters a 30-day option to purchase up to an additional $14,250,000 of common stock to cover over-allotments, if any.
Part of our role in protecting patients is to regularly evaluate, monitor and update scientific evidence on the risks from medical devices—including issues related to the materials used in devices, such as metals.
Peregrine Pharmaceuticals, Inc., today announced that a research article titled "A Monoclonal Antibody that Binds Anionic Phospholipids on Tumor Blood Vessels Enhances the Antitumor Effect of Docetaxel on Human Breast Tumors in Mice" was published in the May 15 issue of Cancer Research.
Cigarette smoking, head injury, farming, pesticide exposure, and a lower level of education may be risk factors for idiopathic rapid eye movement sleep behavior disorder, researchers report.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Richard Stewart, NP 915 Highland Blvd, Bozeman, MT 59715-6902 Ph: (406) 414-5000 | Richard Stewart, NP 206 Alaska Frontage Rd, Belgrade, MT 59714-7909 Ph: (406) 414-3334 |
News Archive
Lexicon Pharmaceuticals, Inc. today announced that it is offering to sell, subject to market and other conditions, $95,000,000 of its common stock pursuant to an effective shelf registration statement in an underwritten public offering. Lexicon also intends to grant the underwriters a 30-day option to purchase up to an additional $14,250,000 of common stock to cover over-allotments, if any.
Part of our role in protecting patients is to regularly evaluate, monitor and update scientific evidence on the risks from medical devices—including issues related to the materials used in devices, such as metals.
Peregrine Pharmaceuticals, Inc., today announced that a research article titled "A Monoclonal Antibody that Binds Anionic Phospholipids on Tumor Blood Vessels Enhances the Antitumor Effect of Docetaxel on Human Breast Tumors in Mice" was published in the May 15 issue of Cancer Research.
Cigarette smoking, head injury, farming, pesticide exposure, and a lower level of education may be risk factors for idiopathic rapid eye movement sleep behavior disorder, researchers report.
› Verified 7 days ago
Mrs. Marybeth J Adams, NP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 15 E Main St, Belgrade, MT 59714 Phone: 406-388-7035 | |
Mary Kay Fouhy-thurston, FNP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 403 W Main St, Belgrade, MT 59714 Phone: 406-388-8708 Fax: 406-388-8710 | |
Lynne Arlene Foss, PNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 206 Alaska Frontage Rd, Belgrade, MT 59714 Phone: 406-414-3334 | |
Nikki Hill, FNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 403 W Main St, Belgrade, MT 59714 Phone: 406-388-8708 Fax: 406-388-8710 | |
Danielle Norris, ARNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 206 Alaska Frontage Rd, Belgrade, MT 59714 Phone: 406-414-3334 | |
Mrs. Amy Cunningham Berghold, NP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 19 E Main St, Belgrade, MT 59714 Phone: 406-922-0820 Fax: 406-823-6305 |